US Patent

US9604948 — Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

Method of Use · Assigned to Adverio Pharma GmbH · Expires 2032-11-26 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a novel process for preparing substituted 5-fluoro-1H-pyrazolopyridines, which are used as an intermediate for producing medicaments.

USPTO Abstract

The present application relates to a novel and efficient process for preparing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders. More particularly, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for preparation of the compound of the formula (I) which serves for production of medicaments, for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-3062 — Verquvo
U-3062 — Verquvo
U-3062 — Verquvo

Patent Metadata

Patent number
US9604948
Jurisdiction
US
Classification
Method of Use
Expires
2032-11-26
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Adverio Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.